1. Aiding early clinical drug development by elucidation of the relationship between tumor growth inhibition and survival in relapsed/refractory multiple myeloma patients. Issue 3 (2nd June 2022) Authors: Cheng, Yiming; Hong, Kevin; Chen, Nianhang; Yu, Xin; Peluso, Teresa; Zhou, Simon; Li, Yan Journal: EJHaem Issue: Volume 3:Issue 3(2022) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First‐in‐Human, Single‐ and Multiple‐Ascending‐Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator. Issue 5 (23rd September 2020) Authors: Ye, Ying; Gaudy, Allison; Schafer, Peter; Thomas, Michael; Weiss, Daniel; Chen, Nianhang; Liu, Liangang; Xue, Yongjun; Carayannopoulos, Leon; Palmisano, Maria Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 5(2021) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy. (5th April 2019) Authors: Wang, Dong; Li, Zhaoyang; Liu, Yi; Chen, Mo; Chen, Nianhang; Zuo, Zhili; Kong, De-Xin Journal: Future medicinal chemistry Issue: Volume 11:Number 8(2019) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lenalidomide at Therapeutic and Supratherapeutic Doses Does Not Prolong QTc Intervals in the Thorough QTc Study Conducted in Healthy Men. (20th June 2013) Authors: Chen, Nianhang; Ye, Ying; Liu, Liangang; Reyes, Josephine; Assaf, Mahmoud S.; Kasserra, Claudia; Zhou, Simon; Palmisano, Maria Journal: Basic & clinical pharmacology & toxicology Issue: Volume 113:Number 3(2013) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study. Issue 3 (March 2016) Authors: Ogura, Michinori; Imaizumi, Yoshitaka; Uike, Naokuni; Asou, Norio; Utsunomiya, Atae; Uchida, Toshiki; Aoki, Tomohiro; Tsukasaki, Kunihiro; Taguchi, Jun; Choi, Ilseung; Maruyama, Dai; Nosaka, Kisato; Chen, Nianhang; Midorikawa, Shuichi; Ohtsu, Tomoko; Tobinai, Kensei Journal: Lancet Issue: Volume 3:Issue 3(2016) Page Start: e107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Multiple‐dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA‐IgG1), a novel erythropoietic agent, in healthy postmenopausal women. (9th September 2013) Authors: Sherman, Matthew L.; Borgstein, Niels G.; Mook, Louisa; Wilson, Dawn; Yang, Yijun; Chen, Nianhang; Kumar, Ravindra; Kim, Kenneth; Laadem, Abderrahmane Journal: Journal of clinical pharmacology Issue: Volume 53:Number 11(2013:Nov.) Page Start: 1121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetics and pharmacodynamics of nab‐paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent‐based paclitaxel. (9th April 2014) Authors: Chen, Nianhang; Li, Yan; Ye, Ying; Palmisano, Maria; Chopra, Rajesh; Zhou, Simon Journal: Journal of clinical pharmacology Issue: Volume 54:Number 10(2014:Oct.) Page Start: 1097 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors. Issue 11 (3rd February 2015) Authors: Abu‐Khalaf, Maysa M.; Baumgart, Megan A.; Gettinger, Scott N.; Doddamane, Indukala; Tuck, David P.; Hou, Shihe; Chen, Nianhang; Sullivan, Catherine; Lezon‐Geyda, Kimberly; Zelterman, Daniel; Hatzis, Christos; Deshpande, Hari; Digiovanna, Michael P.; Azodi, Masoud; Schwartz, Peter E.; Harris, Lynd... Journal: Cancer Issue: Volume 121:Issue 11(2015) Page Start: 1817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. (September 2018) Authors: Moreno, Lucas; Casanova, Michela; Chisholm, Julia C.; Berlanga, Pablo; Chastagner, Pascal B.; Baruchel, Sylvain; Amoroso, Loredana; Gallego Melcón, Soledad; Gerber, Nicolas U.; Bisogno, Gianni; Fagioli, Franca; Geoerger, Birgit; Glade Bender, Julia L.; Aerts, Isabelle; Bergeron, Christophe; Hingo... Journal: European journal of cancer Issue: Volume 100(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network. (August 2020) Authors: Amoroso, Loredana; Castel, Victoria; Bisogno, Gianni; Casanova, Michela; Marquez-Vega, Catalina; Chisholm, Julia C.; Doz, François; Moreno, Lucas; Ruggiero, Antonio; Gerber, Nicolas U.; Fagioli, Franca; Hingorani, Pooja; Melcón, Soledad G.; Slepetis, Ruta; Chen, Nianhang; le Bruchec, Yvan; Simcoc... Journal: European journal of cancer Issue: Volume 135(2020) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗